Value10 in the Pharmaceutical – Medical Equipment sector reflects Nam Ha Pharma’s stable development capacity and long-term orientation within an industry marked by increasing competition and ever more stringent standards.

Amid ongoing global economic uncertainty, the pharmaceutical industry faces growing demands for quality, innovation, and sustainable development. Within this landscape, Nam Ha Pharma is among the few enterprises recognized in the Top 10 Value-Creating Enterprises in Vietnam (Value10) in the Pharmaceutical – Medical Equipment sector.

A benchmark for long-term value creation

Value10 is a nationwide research program focused on identifying enterprises that serve as value pillars of Vietnam’s economy, conducted by Viet Research in collaboration with Báo Đầu tư. What sets Value10 apart is its approach: enterprises are not assessed solely on revenue or profit, but through a comprehensive set of criteria that reflect long-term development capacity.

Enterprises are evaluated based on four key indicator groups: financial performance; contributions to employees and society; investment in innovation and research & development; and commitment to and implementation of ESG (Environmental – Social – Governance) standards. These factors are increasingly becoming common benchmarks in enterprise evaluation across capital markets and global supply chains.

Nam Ha Pharma’s inclusion in the Top 10 Value10 Pharmaceutical – Medical Equipment sector demonstrates that the company not only meets operational efficiency criteria, but is also steadily building a sustainable development foundation aligned with broader industry and economic trends.

Representative of Nam Ha Pharmaceutical Joint Stock Company receiving the award

Operational capability and long-term orientation

Value10 brings together enterprises that play a significant role in sustaining growth momentum and enhancing the competitiveness of the national economy. For Nam Ha Pharma, this recognition reflects the accumulation of internal strength over 65 years of development – through consistent product quality, continuous improvement of governance systems, and proactive adaptation to market fluctuations.

In the face of rising input costs, increasingly rigorous standardization requirements, and intensifying competition, maintaining operational stability while enhancing production and management capabilities is considered a key factor enabling Nam Ha Pharma to create sustainable long-term value.

Notably, alongside its existing product lines, Nam Ha Pharma is progressively implementing a structured and comprehensive development strategy for traditional medicine, spanning from standardizing raw material cultivation areas and strengthening R&D capabilities to refining manufacturing processes in line with increasingly stringent quality standards, with a long-term goal of achieving cGMP (U.S. FDA) compliance. This direction not only leverages traditional strengths, but also aligns with evolving consumer trends and the pharmaceutical industry’s sustainability requirements in the new era.

In parallel, the company continues to prioritize people – building a stable workforce and working environment – while integrating business operations with social responsibility and ESG standards, which are increasingly critical benchmarks in assessing long-term development capacity.

Nam Ha Pharma is among the few leading value-creating enterprises in Vietnam 2025 in the Pharmaceutical – Medical Equipment sector

Advancing toward higher value

The Top 10 Value-Creating Enterprises in Vietnam title represents a significant milestone in Nam Ha Pharma’s development journey, while also extending a series of prestigious recognitions achieved in 2025. Specifically, Nam Ha Pharma has been honored as a Top 5 Most Reputable Oriental Pharmaceutical Company for six consecutive years, ranked among the Top 500 Largest Enterprises in Vietnam for 12 consecutive years, awarded the High-Quality Vietnamese Goods certification for 25 consecutive years, and recognized as a Vietnam National Brand for three consecutive terms. These distinctions reflect stable manufacturing capacity, consistent product quality, and long-term brand credibility recognized by the market.

As Vietnam’s pharmaceutical industry undergoes strong transformation, sustaining long-term value creation requires continued investment in manufacturing systems, research & development, governance enhancement, and increased transparency. These are also the factors increasingly emphasized by the market and investors – particularly for enterprises pursuing sustainable development and a structured, comprehensive approach to traditional medicine like Nam Ha Pharma.

Prestigious certifications recognizing Nam Ha Pharma’s journey of resilient and sustainable development

Repeated recognition by reputable programs not only acknowledges achieved results, but also reflects market expectations for enterprises capable of serving as core pillars, accompanying the sustainable development of the pharmaceutical industry and the broader economy over the long term.